Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Low response to losartan and metformin may be an issue of genetics, not adherence
+Print Archive
Practice
Low response to losartan and metformin may be an issue of genetics, not adherence
Wednesday 17 June 2020, 01:30 AM

Cilazapril/hydrochlorothiazide was recently discontinued, providing an opportunity for blood pressure review in many patients
PHARMACOTHERAPY
Pharmacogenomics is an area that continues to expand, especially for medicines that target specific metabolic pathways or are metabolised by
enzymes that have polymorphisms. This article explores how genetic variation can influence two common medicines
Leanne Te Karu and Linda Bryant
Key points
Losartan may reduce serum urate levels slightly (by 3–10 per cent), but this is not currently predictable.
Losartan is unsuitable a
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.